Comparison of Characteristics and Outcomes of Patients with Acute Myocardial Infarction with versus without Coronarvirus-19

The coronavirus disease 2019 (COVID-19) pandemic has greatly impacted the US healthcare system. Cardiac involvement in COVID-19 is common and manifested by troponin and natriuretic peptide elevation and tends to have a worse prognosis. We analyzed patients who presented to the MedStar Health system (11 hospitals in Washington, DC, and Maryland) with either an ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI) early in the pandemic (March 1, 2020 – June 30, 2020) using the International Classification of Diseases, Tenth Revision.

https://www.ajconline.org/article/S0002-9149(20)31410-7/fulltext?rss=yes

Source: The American Journal of Cardiology - December 29, 2020 Category: Cardiology Authors: Brian C. Case, Charan Yerasi, Brian J. Forrestal, Corey Shea, Hank Rappaport, Giorgio A. Medranda, Cheng Zhang, Lowell F. Satler, Itsik Ben-Dor, Hayder Hashim, Toby Rogers, Ron Waksman Source Type: research